These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 22704116

  • 1. Drugs for lower urinary tract symptoms--anything new?
    Andersson KE.
    J Urol; 2012 Aug; 188(2):349-50. PubMed ID: 22704116
    [No Abstract] [Full Text] [Related]

  • 2. New strategies in treating male lower urinary tract symptoms.
    Füllhase C, Soler R, Gratzke C.
    Curr Opin Urol; 2014 Jan; 24(1):29-35. PubMed ID: 24285261
    [Abstract] [Full Text] [Related]

  • 3. Ketamine-associated urinary tract dysfunction: an underrecognized clinical entity.
    Lai Y, Wu S, Ni L, Chen Z, Li X, Yang S, Gui Y, Guan Z, Cai Z, Ye J.
    Urol Int; 2012 Jan; 89(1):93-6. PubMed ID: 22710265
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin injection for lower urinary tract dysfunction.
    Kuo YC, Kuo HC.
    Int J Urol; 2013 Jan; 20(1):40-55. PubMed ID: 22571329
    [Abstract] [Full Text] [Related]

  • 5. Pharmacology of continence and micturition.
    Bissada NK, Finkbeiner AE.
    Am Fam Physician; 1979 Nov; 20(5):128-36. PubMed ID: 40428
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Defining female voiding dysfunction: ICI-RS 2011.
    Robinson D, Staskin D, Laterza RM, Koelbl H.
    Neurourol Urodyn; 2012 Mar; 31(3):313-6. PubMed ID: 22415792
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lower urinary tract changes in young adults using ketamine.
    Mak SK, Chan MT, Bower WF, Yip SK, Hou SS, Wu BB, Man CY.
    J Urol; 2011 Aug; 186(2):610-4. PubMed ID: 21684556
    [Abstract] [Full Text] [Related]

  • 18. Short-term effects of crossover treatment with silodosin and tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Miyakita H, Yokoyama E, Onodera Y, Utsunomiya T, Tokunaga M, Tojo T, Fujii N, Yanada S.
    Int J Urol; 2010 Oct; 17(10):869-75. PubMed ID: 20735791
    [Abstract] [Full Text] [Related]

  • 19. Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms.
    Sarma AV, Wei JT.
    N Engl J Med; 2012 Jul 19; 367(3):248-57. PubMed ID: 22808960
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.